Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial)-Reference-Cited by-同舟云学术

Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial)

Published:2016-05 Issue: Volume:48 Page:70-75
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Tremoulet Adriana H.,Jain Sonia,Kim Susan,Newburger Jane,Arditi Moshe,Franco Alessandra,Best Brookie^ORCID,Burns Jane C.

Funder

University of California San Diego Department of Pediatrics Intramural Clinical Research

Rady Children's Hospital San Diego Academic Enrichment

Gordon and Marilyn Macklin Foundation

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference54 articles.

1. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist;Aksentijevich;N. Engl. J. Med.,2009

2. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice;Alexander;J. Clin. Invest.,2012

3. Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte derived growth factor;Bonin;Exp. Cell Res.,1989

4. Anakinra use during pregnancy in patients with cryopyrin-associated periodic syndromes (CAPS);Chang;Arthritis Rheum.,2014

5. A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation;Cohen;Ann. Rheum. Dis.,2012

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Central Role of Interleukin-1 Signalling in the Pathogenesis of Kawasaki Disease Vasculitis: Path to Translation;Canadian Journal of Cardiology;2024-07

2. Retrospective evaluation of 130 cases with kawasaki disease follow-up in a tertiary care center in Turkey between 1999 and 2019: a 20-year experience;Postgraduate Medicine;2024-02-17

3. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children;Rheumatic Disease Clinics of North America;2023-08

4. Kawasaki Disease and Innate Immunity;Kawasaki Disease;2023-06

5. Multisystem Inflammatory Syndrome therapies in children (MISTIC): A randomized trial;Contemporary Clinical Trials Communications;2023-04